|
|
|
|
Downloadable files
|
|
Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
|
|
|
|
|
|
|
|
Notice of Funding Availability (NOFA)
|
|
|
|
|
|
Download NOFA
TI 04-005:
Word
Document
Acrobat
Document
|
|
Funding Opportunity Title:
Drug-Addiction-Treatment-Act-of-2000
(DATA)
(Title
XXXV of the Children's Health Act of 2000)
Physician Clinical Support System
|
|
|
|
|
|
Announcement Type: Initial
|
|
|
|
|
|
Funding Opportunity Number: TI 04-005
|
|
|
|
|
|
|
|
Catalog of Federal Domestic Assistance (CFDA) Number: 93.243
|
|
|
|
|
|
Scroll
down for more links |
|
Due Date for Applications: June 2, 2004
|
|
|
|
|
|
|
|
[Note: Letters from State Single Point of Contact (SPOC)
in response to E.O. 12372 are due August
1, 2004.]
|
|
|
|
|
|
|
|
|
|
|
|
SUMMARY:
The Substance Abuse and Mental Health Services Administration
(SAMHSA), Center for Substance Abuse Treatment (CSAT), announces the availability
of FY 2004 funds for the Drug-Addiction-Treatment-Act-of-2000 (DATA)
(Title XXXV of the Children's Health Act of 2000) Physician Clinical Support
System (Short Title: DATA Physician Clinical Support System).
A synopsis of this funding opportunity, as well as many other Federal
Government funding opportunities, is also available at the Internet site:
www.grants.gov.
|
|
|
|
|
|
Download
Standard Announcement
INF-04
PA [MOD]
|
|
For complete instructions, potential applicants must obtain
a copy of SAMHSA's
standard Infrastructure Grants Program Announcement (INF-04 PA [MOD]),
and the PHS 5161-1 (Rev. 7/00) application form before preparing and submitting
an application. The INF-04 PA (MOD) describes the general program design
and provides instructions for applying for all SAMHSA Infrastructure Grants,
ncluding the DATA Physician Clinical Support System. SAMHSA's Infrastructure
Grants provide funds to increase the capacity of mental health and/or
substance abuse service systems to support effective programs and services.
Additional instructions and specific requirements for this funding
opportunity are described below.
|
|
|
|
|
|
|
|
I. Funding Opportunity Description
AUTHORITY: : Section 509 of the
Public Health Service Act, as amended, and subject to the availability
of funds
The purpose of the DATA Physician Clinical Support System cooperative
agreement is to develop a coordinated, clinical support program for physicians
who are treating addicted patients with buprenorphine products.
The target participants for the clinical support system are primary care
physicians, pain specialists, psychiatrists and other non-addiction medical
practitioners, who are often reluctant to treat addicted patients and
are not as familiar with opioid addiction treatment as addictions specialists
are. However, addictions specialists will also be encouraged to
participate in the DATA Physician Clinical Support System or to serve
as mentors.
Applicants are expected to develop a coherent, well-designed
program to assist physicians in developing the skills and confidence to
treat addicted patients, thereby reducing resistance and barriers to the
availability of treatment. By enlisting the assistance of professional
medical groups and other organizations, the grantee will offer physicians
the information and consultation they need to provide safe and effective
buprenorphine treatment.
|
|
|
|
|
|
|
|
Applicants must select activities from the following
list of infrastructure development activities, as appropriate to their
proposed project:
-
Provider/network development (i.e., physician clinical
support network/system development to inform physicians of established
standards of care);
-
Organizational/structural change (e.g., to increase
access to and efficiency of services);
-
Development of the physician workforce;
-
Development of interagency coordination mechanisms
(between national professional medical organizations or related organizations);
and
-
Quality improvement efforts.
|
|
|
|
Applicants must demonstrate the ability to provide consultative
services, telephone consultation, on-site training, observation of practice,
and peer mentoring to physicians treating patients for opioid addiction.
Applicants may propose other activities, such as conducting a limited
number of regional meetings or online Web conferences to improve physician
workforce performance.
Physician support activities must focus on the following content
areas:
-
Assessment and diagnosis using the Diagnostic and
Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR);
-
Induction, maintenance, and detoxification protocols;
-
Strategies to avoid complications and treat them;
-
Ancillary medications;
-
Recommended visit and monitoring schedules;
-
Special psychosocial strategies on motivating patients,
setting limits, or implementing contingency plans;
-
Medically supervised withdrawal and opioid withdrawal
scales;
-
Referrals to counseling, other ancillary services,
or self-help groups;
-
Diagnosis and treatment of psychiatric co-morbidities
or co-occurring disorders, including, but not limited to,
chronic pain, poly-substance abuse, hepatitis C and HIV disease;
-
HIV screening, counseling, testing, and referrals;
-
Referrals to higher levels of care;
-
Special needs patients, including pregnant, adolescent,
and elderly patients; and
-
Important patient recovery indicators.
|
|
|
|
Background:
The need for medication-assisted treatment for opioid addiction
greatly exceeds the Nation's treatment capacity. To address this
long-standing problem, the Drug Addiction Treatment Act of 2000 (DATA)
was enacted to allow trained, qualified physicians to prescribe specifically
approved narcotic medications for the treatment of opioid addiction in
their offices or settings outside traditional opioid treatment programs.
The Food and Drug Administration approved two brand-name medications containing
buprenorphine for this treatment in 2002. SAMHSA was assigned responsibility
to assist with training physicians under DATA. Approximately 4,000
physicians have been trained and 2,500 are approved
to prescribe these medications. Yet, the stigma of addiction tends
to discourage primary care physicians from obtaining training and treating
this population. Also, the lack of physician experience, concerns
over practical issues, and limited understanding of the appropriate role
of medication in opioid treatment all appear to be factors
in the slow adoption of this form of treatment intervention
by the medical profession.
|
|
|
|
|
|
|
|
II. Award Information
1. Estimated Funding Available/Number of Awards:
It is expected that up to $500,000 will be available to fund one
award in FY 2004. The maximum allowable award for this
Category I- Small Infrastructure Grant Award is $500,000 in total
costs (direct and indirect) per year for up to 3 years. Proposed
budgets cannot exceed the allowable amount in any year of the proposed
project. The actual amount available for the award may vary, depending
on unanticipated program requirements and the number and quality of
the applications received. Annual continuations will depend on
the availability of funds, grantee progress in meeting program goals
and objectives, and timely submission of required data and reports.
2. Funding Instrument: Cooperative Agreement
|
|
|
|
Roles and
Responsibilities of Federal Staff: Federal staff members will:
-
Participate in the selection of physician and non-physician
members of a steering committee that will plan, implement, and coordinate
the support system;
-
Assist the grantee to plan for health care infrastructure
development;
-
Help to establish measures of cost-effectiveness;
-
Assist the grantee to meet quality improvement goals;
-
Ensure that consultation services are provided to
the regions of the country with the greatest need;
-
Provide advice and assistance in developing the evaluation;
-
Foster learning and collaboration and coordinate
with other SAMHSA-funded activities, such as the DATA waiver program,
the DATA evaluation, and Addiction Technology Transfer Centers (ATTCs);
and
-
Provide some of the on-site training, observation
of practice, consultative services, peer mentoring, and other services
envisioned under this program.
The Government Project Officer (GPO) will serve as a voting
member of the steering committee, but will not chair the committee.
|
|
|
|
Roles and Responsibilities of Grantee: The
grantee will be required to establish a steering committee to oversee
the development of the Physician Clinical Support System and determine
the direction of the project. Steering committee membership will
be comprised of representatives from participating national professional
medical organizations authorized by law to conduct DATA training, other
stakeholders, and the GPO. The steering committee will be required
to meet, at a minimum, yearly and confer by conference call quarterly
to develop strategies to bring the project to fruition. The grantee
is also expected to implement and evaluate the program in full cooperation
with SAMSHA staff members and contractors. The grantee also will
be required to:
-
Comply with all aspects of the terms and conditions
of the cooperative agreement (to be issued with the award);
-
Participate in selecting a chairperson for the steering
committee;
-
Provide required reports, including those related
to the Government Performance and Results Act (GPRA); and
-
Respond to requests for information or data related
to the program.
|
|
|
|
III. Eligibility Information
1.
Eligible Applicants: Eligibility is limited
to the national professional medical organizations authorized by DATA
to carry out training. These are the American Society
of Addiction Medicine, the American Academy of Addiction Psychiatry,
the American Medical Association, the American Osteopathic Association,
and the American Psychiatric Association.
While any of these entities may apply individually, SAMHSA
encourages a consortium comprised of all or several eligible organizations
to apply. If a consortium is formed for this purpose, a single
organization in the consortium must be the legal applicant, the recipient
of the award, and the entity legally responsible for satisfying the
grant requirements. If a consortium submits an application, the
application must include a written agreement outlining the roles and
responsibilities of each participating national professional medical
organization. This agreement must be signed by an authorized official
of each member of the consortium and attached to the application as
a new Appendix 4, "Roles and Responsibilities of Participating
National Professional Medical Organizations." These eligibility
criteria supersede the criteria specified in Section III-1 of SAMHSA's
Standard Grant INF-04 PA (MOD).
2.
Cost Sharing or Matching is not required.
3. Other: Applicants must also meet certain application
formatting and submission requirements or the application will be screened
out and will not be reviewed. These requirements are described
in Section IV-2 below as well as in the INF-04
PA (MOD).
|
|
|
|
|
|
Go
to Application forms:
PHS
5161-1
and
SF
424
|
|
IV. Application and Submission Information:
1. Address
to Request Application Package:
Complete application kits may be obtained from the National
Clearinghouse for Alcohol and Drug Information (NCADI) at 1-800-729-6686.
When requesting an application kit for this program, the applicant must
specify the funding opportunity title (DATA Physician Clinical Support
System) and the funding opportunity number (TI 04-005). All information
necessary to apply, including where to submit applications and application
deadline instructions, is included in the application kit.
The PHS 5161-1 application form is also available electronically
via SAMHSA's World Wide Web (see left column) and the INF-04 PA (MOD)
is available electronically at /grants/2004/standard/Infrastructure/index.asp.
|
|
|
|
When submitting an application, be sure to type "TI 04-005,
DATA Physician Clinical Support System" in Item Number 10 on the
face page of the application form. Also, SAMHSA applicants are
required to provide a DUNS Number on the face page of the application.
To obtain a DUNS Number, access the Dun and Bradstreet web site at www.dunandbradstreet.com
or call 1-866-705-5711.
|
|
|
|
2. Content and Form of Application Submission:
Information including required documents, required application components,
and application formatting requirements is available in the INF-04
PA (MOD) in Section IV-2.
|
|
|
|
Checklist for Formatting Requirements and Screenout Criteria for SAMHSA
Grant Applications
|
|
|
|
|
|
|
|
SAMHSA's goal is to review all applications submitted for grant funding.
However, this goal must be balanced against SAMHSA's obligation to ensure
equitable treatment of applications. For this reason, SAMHSA has
established certain formatting requirements for its applications.
If you do not adhere to these requirements, your application will be
screened out and returned to you without review.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Use the PHS 5161-1 application.
|
|
|
|
|
|
|
|
Applications must be received by
the application deadline. Applications received after this date must
have a proof of mailing date from the carrier dated at least 1 week prior
to the due date. Private metered postmarks are not acceptable as proof
of timely mailing. Applications not received by the application deadline
or not postmarked at least 1 week prior to the application deadline will
not be reviewed. |
|
|
|
|
|
|
|
Information provided must be sufficient
for review. |
|
|
|
|
|
|
|
Text must be legible.
-
Type size in the Project Narrative cannot
exceed an average of 15 characters per inch, as measured on the physical
page. (Type size in charts, tables, graphs, and footnotes will
not be considered in determining compliance.)
-
Text in the Project Narrative cannot exceed
6 lines per vertical inch.
|
|
|
|
Paper must be
white paper and 8.5 inches by 11.0 inches in size. |
|
|
|
|
|
|
|
To ensure equity among applications, the
amount of space allowed for the Project Narrative cannot be exceeded.
-
Applications would meet this requirement
by using all margins (left, right, top, bottom) of at least one inch
each, and adhering to the page limit for the Project Narrative stated
in the specific funding announcement.
-
Should an application not conform to
these margin or page limits, SAMHSA will use the following method
to determine compliance: The total area of the Project Narrative
(excluding margins, but including charts, tables, graphs and footnotes)
cannot exceed 58.5 square inches multiplied by the page limit.
This number represents the full page less margins, multiplied by the
total number of allowed pages.
-
Space will be measured on the physical
page. Space left blank within the Project Narrative (excluding
margins) is considered part of the Project Narrative, in determining
compliance.
|
|
|
|
The
page limit for Appendices stated in the specific funding announcement
cannot be exceeded.
|
|
|
|
|
|
|
|
To
facilitate review of your application, follow these additional guidelines.
Failure to adhere to the following guidelines will not, in itself,
result in your application being screened out and returned without review.
However, the information provided in your application must be sufficient
for review. Following
these guidelines will help ensure your application is complete, and will
help reviewers to consider your application.
|
|
|
|
|
|
|
|
The 10 application components required for SAMHSA applications must be
included:
-
Face Page (Standard Form 424, which
is in PHS 5161-1)
-
Abstract
-
Table of Contents
-
Budget Form (Standard Form 424A, which
is in PHS 5161-1)
-
Project Narrative and Supporting Documentation
-
Appendices
-
Assurances (Standard Form 424B, which
is in PHS 5161-1)
-
Certifications (a form in PHS 5161-1)
-
Disclosure of Lobbying Activities (Standard
Form LLL, which is in PHS 5161-1)
-
Checklist (a form in PHS 5161-1)
|
|
|
|
Applications should comply with
the following requirements:
-
Provisions relating to confidentiality,
participant protection and the protection of human subjects, as indicated
in the specific funding announcement.
-
Budgetary limitations as indicated in
Sections I, II, and IV-5 of the specific funding announcement.
-
Documentation of nonprofit status as
required in the PHS 5161-1.
|
|
|
|
Pages should be typed single-spaced
with one column per page. |
|
|
|
|
|
|
|
Pages should not have printing
on both sides. |
|
|
|
|
|
|
|
Please use black ink, and number
pages consecutively from beginning to end so that information can be located
easily during review of the application. The cover page should be
page 1, the abstract page should be page 2, and the table of contents page
should be page 3. Appendices should be labeled and separated from the Project
Narrative and budget section, and the pages should be numbered to continue
the sequence. |
|
|
|
|
|
|
|
Send the original application and
two copies to the mailing address in the funding announcement. Please
do not use staples, paper clips, and fasteners. Nothing should be
attached, stapled, folded, or pasted. Do not use heavy or lightweight
paper, or any material that cannot be copied using automatic copying machines.
Odd-sized and oversized attachments such as posters will not be copied or
sent to reviewers. Do not include videotapes, audiotapes, or CD-ROMs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3. Submission Dates and Times:
Applications must be received by June 2, 2004.
You will be notified by postal mail that your application has been received.
Additional submission information is available in the INF-04
PA (MOD) in Section IV-3.
|
|
|
|
4. Intergovernmental Review:
Applicants for this funding opportunity must comply with Executive
Order 12372 (E.O.12372). E.O.12372, as implemented through Department
of Health and Human Services (DHHS) regulation at 45 CFR Part 100, sets
up a system for State and local review of applications for Federal financial
assistance. Instructions for complying with E.O. 12372 are provided
in the SVC-04 PA (MOD) in Section IV-4. A current listing of State
Single Points of Contact (SPOCs) is included in the application kit
and is available at www.whitehouse.gov/omb/grants/spoc.html.
|
|
|
|
5. Funding Restrictions:
Information concerning funding restrictions
is available in the INF-04
PA (MOD) in Section IV-5. Funds for the DATA Physician Clinical
Support System program may not be used for the following activities
allowed in the INF 04-PA (MOD) in Section I-2:
-
Needs assessment;
-
Strategic planning;
-
Financing/coordination of funding
streams;
-
Policy development to support needed
service improvements (e.g., rate-setting activities, establishment
of standards of care, development/ revision of credentialing, licensure,
or accreditation requirements);
-
Performance measurement development;
or
-
Data infrastructure/MIS development.
In addition, the grantee may not use funds
for training physicians to qualify for the DATA waiver. SAMHSA
already has adequate mechanisms in place to subsidize the 8-hour training
that is required for some candidates to meet DATA qualification requirements.
|
|
|
|
V. Application Review Information
1. Evaluation Criteria:
Applications will be reviewed against the Evaluation Criteria
and requirements for the Project Narrative specified in the INF-04
PA (MOD). The following information
describes the exceptions or limitations to the INF-04 PA (MOD) and provides
special requirements that pertain only to the DATA Physician Clinical
Support System program. Applicants for
the DATA Physician Clinical Support System program are required to discuss
the following requirements in their applications, in addition to the
requirements specified in the INF-04 PA (MOD):
|
|
|
|
1.1
In "Section A: Statement of Need":
a.
Applicants must address the issues/needs of the target population.
The target population for this program is the population of persons
with opioid addiction disorders. The catchment area is the Nation
as a whole.
b.
Applicants do not have to respond to the fourth bullet, which
requires applicants to ".show that identified needs are consistent with
priorities of the State or county that has primary responsibility for
the service delivery system.
|
|
|
|
1.2 In "Section B: Proposed Approach":
Applicants must describe how stakeholders and other organizations
that choose to participate in the proposed project will collaborate
with each other in implementing the DATA Physician Clinical Support
System.
|
|
|
|
1.3 Applicants must provide "Roles and
Responsibilities of Participating National Professional Medical Organizations,"
as a new Appendix 4 of the application rather than the Letter
to the SSA as described in Section IV-2.2 in the INF-04 PA (MOD).
|
|
|
|
1.4 Applicants do not have to include
Appendix 5, Copy of State or County Strategic Plan, as specified
in the INF-04 PA (MOD) in their applications.
|
|
SAMHSA/CSAT
Government
Performance and Results Act (GPRA) |
|
1.5 Performance Measurement:
All SAMHSA grantees are required to collect and report
certain data so that SAMHSA can meet its obligations under the Government
Performance and Results Act (GPRA). The DATA Physician Clinical
Support System grantee will be required to report on the following:
-
Number of consultation events, training events, technical
assistance events or contacts;
-
Number of physicians participating in each event;
-
Percentage of physicians satisfied with educational
and support services offered; and
-
Percentage of physicians who report that consultation
or training events resulted in appropriate practice change(s).
Applicants must document their ability to collect and report
on these measures in "Section D: Evaluation and Data." The grantee
will be required to use the relevant data collection instruments approved
by OMB for collecting customer satisfaction data, e.g., the CSAT Baseline
Meeting Satisfaction Survey, the CSAT Follow-up Meeting Satisfaction
Survey, the CSAT Baseline Training Satisfaction Survey, or the CSAT
Follow-up Training Satisfaction Survey. These instruments are
available at https://www.samhsa-gpra.samhsa.gov/knowledge.cfm.
Hard copies of the instruments are available in the application
kits distributed by SAMHSA's National Clearinghouse for Alcohol and
Drug Information (NCADI). Training and technical assistance on
data collection and entry will be provided by CSAT.
|
|
|
|
2. Review and Selection
Process:
Information about the review and
selection process is available in the
INF-04 PA (MOD) in Section V-2.
|
|
|
|
VI.
Award Administration Information:
Award administration information, including award notices, administrative
and national policy requirements, and reporting requirements are available
in the INF-04 PA (MOD) in Section VI. SAMHSA's standard terms and conditions
are available at www.samhsa.gov/grants/2004/useful_info.asp
|
|
|
|
|
|
|
|
VII.
Agency Contact for Additional Information:
For questions concerning program issues, contact:
Raymond Hylton, RN, MSN, SAMHSA/Center for Substance Abuse Treatment,
DPT, 5600 Fishers Lane, Rockwall II, Suite 618, Rockville, MD 20857; 301-443-6502;
E-mail: rhylton@samhsa.hhs.gov.
For questions on grants management issues, contact: Kathleen
Sample, SAMHSA/Division of Grants Management, 5600 Fishers Lane, Rockwall
II, Suite 630, Rockville, MD 20857; 301-443-9667; E-mail: ksample@samhsa.hhs.gov.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dated:
March 19, 2004
|
Signed:
Daryl Kade
Director, Office of Policy, Planning and Budget
Substance Abuse and Mental Health Services Administration
|
|